TY - JOUR AU - Nicolson, G. L. PY - 1988 DA - 1988// TI - Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites JO - Cancer Metastasis Rev VL - 7 UR - https://doi.org/10.1007/BF00046483 DO - 10.1007/BF00046483 ID - Nicolson1988 ER - TY - JOUR AU - Albini, A. AU - Benelli, R. AU - Noonan, D. M. AU - Brigati, C. PY - 2004 DA - 2004// TI - The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes JO - Int J Dev Biol VL - 48 UR - https://doi.org/10.1387/ijdb.041822aa DO - 10.1387/ijdb.041822aa ID - Albini2004 ER - TY - JOUR AU - Berezovskaya, O. AU - Schimmer, A. D. AU - Glinskii, A. B. AU - Pinilla, C. AU - Hoffman, R. M. AU - Reed, J. C. AU - Glinsky, G. V. PY - 2005 DA - 2005// TI - Increased Expression of Apoptosis Inhibitor Protein XIAP Contributes to Anoikis Resistance of Circulating Human Prostate Cancer Metastasis Precursor Cells JO - Cancer Research VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-2649 DO - 10.1158/0008-5472.CAN-04-2649 ID - Berezovskaya2005 ER - TY - JOUR AU - Fernandez, Y. AU - Espana, L. AU - Manas, S. AU - Fabra, A. AU - Sierra, A. PY - 2000 DA - 2000// TI - Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance JO - Cell Death Differ VL - 7 UR - https://doi.org/10.1038/sj.cdd.4400662 DO - 10.1038/sj.cdd.4400662 ID - Fernandez2000 ER - TY - JOUR AU - Condon, M. S. PY - 2004 DA - 2004// TI - The role of the stromal microenvironment in prostate cancer JO - Seminars in Cancer Biology VL - 15 UR - https://doi.org/10.1016/j.semcancer.2004.08.002 DO - 10.1016/j.semcancer.2004.08.002 ID - Condon2004 ER - TY - JOUR AU - Stewart, D. A. AU - Cooper, C. R. AU - Sikes, R. A. PY - 2004 DA - 2004// TI - Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer JO - Reprod Biol Endocrinol VL - 2 UR - https://doi.org/10.1186/1477-7827-2-2 DO - 10.1186/1477-7827-2-2 ID - Stewart2004 ER - TY - JOUR AU - Sidenius, N. AU - Blasi, F. PY - 2003 DA - 2003// TI - The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy JO - Cancer Metastasis Rev VL - 22 UR - https://doi.org/10.1023/A:1023099415940 DO - 10.1023/A:1023099415940 ID - Sidenius2003 ER - TY - JOUR AU - Duffy, M. J. PY - 2002 DA - 2002// TI - Urokinase plasminogen activator and its inhibitor PAI-1 as prognostic markers in breast cancer: from pilot to level 1 evidence studies JO - Clin Chem VL - 48 ID - Duffy2002 ER - TY - JOUR AU - Alfano, D. AU - Franco, P. AU - Vocca, I. AU - Gambi, N. AU - Pisa, V. AU - Mancini, A. AU - Caputi, M. AU - Carriero, M. V. AU - Iaccarino, I. AU - Stoppelli, M. P. PY - 2005 DA - 2005// TI - The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis JO - Thromb Haemost VL - 93 ID - Alfano2005 ER - TY - JOUR AU - Alfano, D. AU - Iaccarino, I. AU - Stoppelli, M. P. PY - 2006 DA - 2006// TI - Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M601812200 DO - 10.1074/jbc.M601812200 ID - Alfano2006 ER - TY - JOUR AU - Miyake, H. AU - Hara, I. AU - Yamanaka, K. AU - Gohji, K. AU - Arakawa, S. AU - Kamidono, S. PY - 1999 DA - 1999// TI - Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer JO - Prostate VL - 39 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Miyake1999 ER - TY - JOUR AU - McCabe, N. P. AU - Angwafo, F. F. AU - Zaher, A. AU - Selman, S. H. AU - Kouinche, A. AU - Jankun, J. PY - 2000 DA - 2000// TI - Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients JO - Oncol Reports VL - 7 ID - McCabe2000 ER - TY - JOUR AU - Piironen, T. AU - Haese, A. AU - Huland, H. AU - Steuber, T. AU - Christensen, I. J. AU - Brunner, N. AU - Dano, K. AU - Hoyer-Hansen, G. AU - Lilja, H. PY - 2006 DA - 2006// TI - Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum JO - Clin Chem VL - 52 UR - https://doi.org/10.1373/clinchem.2005.064253 DO - 10.1373/clinchem.2005.064253 ID - Piironen2006 ER - TY - JOUR AU - Gavrilov, D. AU - Kenzior, O. AU - Evans, M. AU - Calaluce, R. AU - Folk, W. R. PY - 2001 DA - 2001// TI - Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers JO - Eur J Cancer VL - 37 UR - https://doi.org/10.1016/S0959-8049(01)00077-6 DO - 10.1016/S0959-8049(01)00077-6 ID - Gavrilov2001 ER - TY - JOUR AU - Usher, P. A. AU - Thomsen, O. F. AU - Iversen, P. AU - Johnsen, M. AU - Brunner, N. AU - Hoyer-Hansen, G. AU - Andreasen, P. AU - Dano, K. AU - Nielsen, B. S. PY - 2005 DA - 2005// TI - Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue JO - Int J Cancer VL - 113 UR - https://doi.org/10.1002/ijc.20665 DO - 10.1002/ijc.20665 ID - Usher2005 ER - TY - JOUR AU - Heiss, M. M. AU - Simon, E. H. AU - Beyer, B. C. AU - Gruetzner, K. U. AU - Tarabichi, A. AU - Babic, R. AU - Schildberg, F. W. AU - Allgayer, H. PY - 2002 DA - 2002// TI - Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.08.003 DO - 10.1200/JCO.2002.08.003 ID - Heiss2002 ER - TY - JOUR AU - Margheri, F. AU - D'Alessio, S. AU - Serrati, S. AU - Pucci, M. AU - Annunziato, F. AU - Cosmi, L. AU - Liotta, F. AU - Angeli, R. AU - Angelucci, A. AU - Gravina, G. L. AU - Rucci, N. AU - Bologna, M. AU - Teti, A. AU - Monia, B. AU - Fibbi, G. AU - Del Rosso, M. PY - 2005 DA - 2005// TI - Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases JO - Gene Therapy VL - 12 UR - https://doi.org/10.1038/sj.gt.3302456 DO - 10.1038/sj.gt.3302456 ID - Margheri2005 ER - TY - JOUR AU - Rabbani, S. A. AU - Gladu, J. PY - 2002 DA - 2002// TI - Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo JO - Cancer Research VL - 62 ID - Rabbani2002 ER - TY - JOUR AU - Pulukuri, S. M. AU - Gondi, C. S. AU - Lakka, S. S. AU - Jutla, A. AU - Estes, N. AU - Gujrati, M. AU - Rao, J. S. PY - 2005 DA - 2005// TI - RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M503111200 DO - 10.1074/jbc.M503111200 ID - Pulukuri2005 ER - TY - JOUR AU - Chu, J. H. AU - Sun, Z. Y. AU - Meng, X. L. AU - Wu, J. H. AU - He, G. L. AU - Liu, G. M. AU - Jiang, X. R. PY - 2006 DA - 2006// TI - Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells JO - Cancer Letters VL - 233 UR - https://doi.org/10.1016/j.canlet.2005.03.034 DO - 10.1016/j.canlet.2005.03.034 ID - Chu2006 ER - TY - JOUR AU - Frisch, S. M. AU - Ruoslahti, E. PY - 1997 DA - 1997// TI - Integrins and anoikis JO - Curr Opin Cell Biol VL - 9 UR - https://doi.org/10.1016/S0955-0674(97)80124-X DO - 10.1016/S0955-0674(97)80124-X ID - Frisch1997 ER - TY - JOUR AU - Forbes, K. AU - Gillette, K. M. AU - Kelly, L. AU - Sehgal, I. PY - 2004 DA - 2004// TI - Urokinase Plasminogen Activator Receptor (uPAR) is increased in re-metastasized prostate cancer cells JO - World Journal of Urology VL - 22 UR - https://doi.org/10.1007/s00345-003-0395-3 DO - 10.1007/s00345-003-0395-3 ID - Forbes2004 ER - TY - JOUR AU - Ruoslahti, E. AU - Reed, J. C. PY - 1994 DA - 1994// TI - Anchorage dependence, integrins, and apoptosis JO - Cell VL - 77 UR - https://doi.org/10.1016/0092-8674(94)90209-7 DO - 10.1016/0092-8674(94)90209-7 ID - Ruoslahti1994 ER - TY - JOUR AU - Rennebeck, G. AU - Martelli, M. AU - Kyprianou, N. PY - 2005 DA - 2005// TI - Anoikis and survival connections in the tumor microenvironment: Is there a role in prostate cancer metastasis? JO - Cancer Research VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-2763 DO - 10.1158/0008-5472.CAN-05-2763 ID - Rennebeck2005 ER - TY - JOUR AU - Li, L. AU - Ren, C. H. AU - Tahir, S. A. AU - Ren, C. AU - Thompson, T. C. PY - 2203 DA - 2203// TI - Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A JO - Mol Cell Biol VL - 23 UR - https://doi.org/10.1128/MCB.23.24.9389-9404.2003 DO - 10.1128/MCB.23.24.9389-9404.2003 ID - Li2203 ER - TY - JOUR AU - Nguyen, D. H. D. AU - Hussaini, I. M. AU - Gonias, S. L. PY - 1998 DA - 1998// TI - Binding of urokinase-type plasminogen activator to its receptor in MCF-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.14.8502 DO - 10.1074/jbc.273.14.8502 ID - Nguyen1998 ER - TY - JOUR AU - Barnathan, E. S. AU - Kuo, A. AU - Kariko, K. AU - Rosenfeld, L. AU - Murray, S. C. AU - Behrendt, N. AU - Ronne, E. AU - Weiner, D. AU - Henkin, J. AU - Cines, D. B. PY - 1990 DA - 1990// TI - Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA JO - Blood VL - 76 ID - Barnathan1990 ER -